Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

U.K. Pharmas, Regulators Agree on Faster Drug Review

Dispensing pills

Drug makers and regulators in the U.K. agreed on new review processes for more effective therapies in company pipelines, in exchange for caps on branded drug sales, which is expected to save £930 million ($US 1.2 billion) next year. . . . → Read More: U.K. Pharmas, Regulators Agree on Faster Drug Review

Report – U.S. Lags in Robotic Adoption

Robots Sawyer and Baxter

A report released today shows the U.S. and most European countries are falling behind most other developed countries, in adopting robotics into their economies. . . . → Read More: Report – U.S. Lags in Robotic Adoption

Trial Shows Treatment Prevents Peanut Allergy Reactions

Peanutes in shells

Final results from a clinical trial show a preventive treatment desensitizes children and adolescents with peanut allergies against reaction-causing proteins in peanuts for one year. . . . → Read More: Trial Shows Treatment Prevents Peanut Allergy Reactions

Faster Crop Breeding Techniques Made Available to Other Scientists

Growing wheat

Plant scientists in the U.K. and Australia are making available to their colleagues experimental techniques that speed-up breeding cycles for more commercial crop varieties. . . . → Read More: Faster Crop Breeding Techniques Made Available to Other Scientists

Biotechs to Develop Personal Cancer-Killing Virus Vaccines

Adenovirus illustration

Two biotechnology companies developing engineered viruses as cancer therapies plan to create personalized treatments for solid tumors with viruses that harness the immune system. . . . → Read More: Biotechs to Develop Personal Cancer-Killing Virus Vaccines

RNA Therapeutics Company Raises $30M in First Venture Round

Kevin Weeks

A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells. . . . → Read More: RNA Therapeutics Company Raises $30M in First Venture Round

Infographic – Superbugs Annually Kill 33,000 in Europe

Chart: Superbug deaths n Europe

Our friends at Statista posted a chart showing the median number of deaths by country in Europe from microbes resistant to antibiotics, this weekend’s infographic. . . . → Read More: Infographic – Superbugs Annually Kill 33,000 in Europe

Munich Airport, MIT Lab Partner on Smart City

Munich airport

An engineering lab at MIT and the R&D hub at Munich, Germany’s international airport are studying the use of digital technologies to improve urban life, using the hub’s campus as a laboratory. . . . → Read More: Munich Airport, MIT Lab Partner on Smart City

Rapid Antimicrobial Resistance Diagnostics System Advances

MRSA bacteria

Developers of a system that uses high-speed genomic analysis with standard semiconductor chips say they demonstrated an ability to sequence bacterial DNA directly from raw blood samples. . . . → Read More: Rapid Antimicrobial Resistance Diagnostics System Advances

BASF Licensing Precise Crispr Editing from Broad Institute

Crispr-Cas9 illustration

The global chemical company BASF is licensing a more precise form of genome editing from the Broad Institute, a genetics research center affiliated with Harvard University and MIT. . . . → Read More: BASF Licensing Precise Crispr Editing from Broad Institute